Linguamatics is proud to be a gold sponsor at World Drug Safety Congress Europe 2021, 6-7 October, find us in booth 8!
Linguamatics' Dr. Jane Reed will be presenting "NLP-based AI for safety applications in Pharma", AI & Automation track; NLP-based AI for safety applications in Pharma; on Wednesday October 6 from 15:35pm BST
Life science companies are actively pursuing innovative technologies to address the challenge of managing increasing volumes of safety-related data from new and disparate sources. Technologies such as artificial intelligence (AI), and natural language processing (NLP) can be applied to identify AEs, extract and standardize data and look for signals in both structured and unstructured data.
We will share use cases from top 20 pharma organizations who are using NLP to support safety applications from preclinical toxicology through to post-market safety and translational research. These include:
- NLP to identify patients at risk in a clinical trial
- NLP within intake for safety case processing
- NLP to assist with remediation of records in response to regulatory alerts
- NLP to develop landscape of safety-related intelligence from scientific literature and internal preclinical and clinical safety reports.